TransEnterix (TRXC) Misses Q4 EPS by 1c, Says Audit Opinion Includes Explanatory Paragraph Related to Going Concern
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2015
March 3, 2016 4:05 PM ESTRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full year 2015.
Full Year 2015 Operating Highlights
· Completed Acquisition of the ALF-X® System from SOFAR S.p.A.
· Submitted 510(k) Application to the FDA for the SurgiBot System
· Raised $58.3 Million in Net Proceeds from Equity and Debt Transactions
· Strengthened Global Leadership Team with the Appointment of Senior... More
